Asco 2025 · Posters · Cáncer Genitourinario ·
David Olmos, MD, PhD
Asco 2025 · Posters · Cáncer Genitourinario ·
David Olmos, MD, PhD
Impact of somatic/germline homologous recombination repair (HRR) alterations on metastatic hormone-sensitive prostate cancer (mHSPC) outcomes by disease volume.